Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Consumer News Weight Loss Drugs May Come With Serious Digestive Risks

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Weight Loss Drugs May Come With Serious Digestive Risks is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Consumer News Weight Loss Drugs May Come With Serious Digestive Risks | RobinsPost News & Noticias

Nearly 3,000 plaintiffs sue over GLP-1 drug side effects


Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through the courts. Thousands of ... Read More

Ozempic is a serious drug with serious risks. Here’s what to know.


The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are downsides—and potentially serious side effects. Read More

FDA approves Wegovy weight loss pill from Novo Nordisk


The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug. The Wegovy pill, as it’s called, is first oral version of a GLP-1 drug that ... Read More

Weight loss medications can cause serious side effects: Experts explain the risks


In recent years, the use of weight-loss medications has surged. Attracted by quick results, many people start taking these drugs without proper medical guidance. Social media has also fueled this ... Read More

New weight-loss shot shows major fat reduction, but experts urge caution


An experimental medication was shown to help boost weight loss by up to 20%, a study found. Eloralintide, a once-weekly injectable manufactured by Eli Lilly in Indianapolis, led to "meaningful, ... Read More

Ozempic is changing how we spend money and time, plus what we eat


Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. Industry insiders are gearing up for weight-loss drugs to shake up the ... Read More

Monday's Daily Dose: Medicare deadline looms, weight loss drug study and ultra-processed food risks


The clock is ticking for Medicare beneficiaries. Open enrollment ends Dec. 7, and healthcare experts say many people are still confused about their options. CEO of NorthCoast Health Care Management, ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus